Pfizer’s updated COVID-19 vaccine for the upcoming fall and winter months has been granted Health Canada approval.
Pfizer’s updated vaccine is approved for people six months and older.
Comments closedTag: Health Canada
Topic: vaccinesView all posts for the topic: vaccines
Health Canada authorizes updated Pfizer-BioNTech COVID vaccine
Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.
The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Health Canada approves Moderna’s updated COVID-19 vaccine
Health Canada has approved Moderna’s updated COVID-19 vaccine for all Canadians who are six months of age and older — while two other options for fall shots remain in the regulatory pipeline.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Moderna’s updated COVID vaccine targeting XBB.1.5 approved in Canada
Health Canada has given the green light to an eagerly anticipated fall COVID-19 booster shot in hopes of bolstering the nation’s defence against the virus as the fall season approaches.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Santé Canada approuve la mise à jour du vaccin de Moderna contre la COVID-19
Health Canada announced on Tuesday that it is authorizing the use of an updated Moderna COVID-19 vaccine for all Canadians over the age of six months, at a time when federal public health has recommended that Canadians roll up their sleeves and return for vaccination.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Will updated COVID vaccines work against latest variant? Canadian scientists monitor global research
Health Canada is currently reviewing applications for Moderna and Pfizer-BioNTech’s new mRNA vaccines, developed against the dominant XBB.1.5 variant ahead of a vaccination campaign set for the fall.
Comments closedCTV News / The Canadian Press
August 4, 2023
Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over, but its use may be “limited” during this fall’s respiratory virus season.
Comments closed